首页 | 本学科首页   官方微博 | 高级检索  
     


Remission of hormone-refractory prostate cancer attributed to Essiac
Authors:Al-Sukhni Wigdan  Grunbaum Ami  Fleshner Neil
Affiliation:Division of Urology, The Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
Abstract:Essiac is a popular complementary and alternative medicine (CAM) that is utilized by many cancer patients in North America. Much anecdotal reporting exists about its cancer-fighting qualities, but so far no clinical trials have been preformed to validate those claims. We describe here the case of a 64-year-old man whose hormone-refractory prostate cancer responded well to Essiac tea.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号